Literature DB >> 23261466

Lipid complex of apolipoprotein A-I mimetic peptide 4F is a novel platform for paraoxonase-1 binding and enhancing its activity and stability.

Vinod K Mishra1, Mayakonda N Palgunachari, David T McPherson, Gattadahalli M Anantharamaiah.   

Abstract

High density lipoprotein (HDL) associated paraoxonase-1 (PON1) is crucial for the anti-oxidant, anti-inflammatory, and anti-atherogenic properties of HDL. Discoidal apolipoprotein (apo)A-I:1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) complex has been shown to be the most effective in binding PON1, stabilizing it, and enhancing its lactonase and inhibitory activity of low density lipoprotein oxidation. Based on our earlier study demonstrating that apoA-I mimetic peptide 4F forms discoidal complex with 1,2-dimyristoyl-sn-glycero-3-phosphocholine, we hypothesized that lipid complexes of 4F would be able to bind PON1 and enhance its activity and stability. To test our hypothesis, we have expressed and purified a recombinant PON1 (rPON1) and studied its interaction with 4F:POPC complex. Our studies show significant increase, compared to the control, in the paraoxonase activity and stability of rPON1 in the presence of 4F:POPC complex. We propose that 4F:POPC complex is a novel platform for PON1 binding, increasing its stability, and enhancing its enzyme activity. We propose a structural model for the 4F:POPC:PON1 ternary complex that is consistent with our results and published observations.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23261466      PMCID: PMC3555693          DOI: 10.1016/j.bbrc.2012.11.128

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

Review 1.  Raising low levels of high-density lipoprotein cholesterol is an important target of therapy.

Authors:  W E Boden; T A Pearson
Journal:  Am J Cardiol       Date:  2000-03-01       Impact factor: 2.778

2.  Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide.

Authors:  G Datta; M Chaddha; S Hama; M Navab; A M Fogelman; D W Garber; V K Mishra; R M Epand; R F Epand; S Lund-Katz; M C Phillips; J P Segrest; G M Anantharamaiah
Journal:  J Lipid Res       Date:  2001-07       Impact factor: 5.922

3.  Sidedness of interfacial arginine residues and anti-atherogenicity of apolipoprotein A-I mimetic peptides.

Authors:  Gaurav Nayyar; Vinod K Mishra; Shaila P Handattu; Mayakonda N Palgunachari; Ronald Shin; David T McPherson; Champion C S Deivanayagam; David W Garber; Jere P Segrest; G M Anantharamaiah
Journal:  J Lipid Res       Date:  2012-02-29       Impact factor: 5.922

4.  Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis.

Authors:  D M Shih; Y R Xia; X P Wang; E Miller; L W Castellani; G Subbanagounder; H Cheroutre; K F Faull; J A Berliner; J L Witztum; A J Lusis
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

5.  Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism.

Authors:  Sara Deakin; Ilia Leviev; Monica Gomaraschi; Laura Calabresi; Guido Franceschini; Richard W James
Journal:  J Biol Chem       Date:  2001-11-28       Impact factor: 5.157

6.  Paraoxonase-1 is a major determinant of clopidogrel efficacy.

Authors:  Heleen J Bouman; Edgar Schömig; Jochem W van Werkum; Janna Velder; Christian M Hackeng; Christoph Hirschhäuser; Christopher Waldmann; Hans-Günther Schmalz; Jurriën M ten Berg; Dirk Taubert
Journal:  Nat Med       Date:  2010-12-19       Impact factor: 53.440

Review 7.  Sequence conservation of apolipoprotein A-I affords novel insights into HDL structure-function.

Authors:  Denys Bashtovyy; Martin K Jones; G M Anantharamaiah; Jere P Segrest
Journal:  J Lipid Res       Date:  2010-12-14       Impact factor: 5.922

8.  Protective efficacy of catalytic bioscavenger, paraoxonase 1 against sarin and soman exposure in guinea pigs.

Authors:  Manojkumar Valiyaveettil; Yonas Alamneh; Peter Rezk; Lionel Biggemann; Michael W Perkins; Alfred M Sciuto; Bhupendra P Doctor; Madhusoodana P Nambiar
Journal:  Biochem Pharmacol       Date:  2011-01-08       Impact factor: 5.858

9.  High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection.

Authors:  B J Van Lenten; A C Wagner; D P Nayak; S Hama; M Navab; A M Fogelman
Journal:  Circulation       Date:  2001-05-08       Impact factor: 29.690

10.  Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes.

Authors:  Michal Harel; Amir Aharoni; Leonid Gaidukov; Boris Brumshtein; Olga Khersonsky; Ran Meged; Hay Dvir; Raimond B G Ravelli; Andrew McCarthy; Lilly Toker; Israel Silman; Joel L Sussman; Dan S Tawfik
Journal:  Nat Struct Mol Biol       Date:  2004-04-18       Impact factor: 15.369

View more
  4 in total

Review 1.  High-density lipoprotein mimetics: promises and challenges.

Authors:  Dmitri Sviridov; Alan T Remaley
Journal:  Biochem J       Date:  2015-12-15       Impact factor: 3.857

Review 2.  Apolipoprotein A-I mimetics.

Authors:  Srinivasa T Reddy; Mohamad Navab; Gattadahalli M Anantharamaiah; Alan M Fogelman
Journal:  Curr Opin Lipidol       Date:  2014-08       Impact factor: 4.776

3.  High-Resolution Structural Studies Elucidate Antiatherogenic and Anti-Inflammatory Properties of Peptides Designed to Mimic Amphipathic α-Helical Domains of Apolipoprotein A-I.

Authors:  Vinod K Mishra; Gattadahalli M Anantharamaiah
Journal:  Nat Prod Commun       Date:  2019-05-28       Impact factor: 1.496

Review 4.  Antioxidant properties of HDL.

Authors:  Handrean Soran; Jonathan D Schofield; Paul N Durrington
Journal:  Front Pharmacol       Date:  2015-10-16       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.